MALAT1 and cervical cancer: To sum up, these findings suggested that the exosomal MALAT1/miR-370-3p/STAT3 loop affects the PI3K/AKT pathway mediating the cisplatin resistance of cervical cancer cells, which provides a promising exosomal lncRNA targeting therapy for CC patients and an important theoretical basis for CC therapy.